Hepatopoietin and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 29, 2013
Grant Date -
Jun 10, 2010
app pub date -
Dec 21, 2007
filing date -
Dec 26, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided are a hepatopoietin PCn (HPPCn) and its homologous proteins, which can promote hepatocyte proliferation in vitro, promote liver regeneration in vivo, inhibit the growth of tumor cells and promote the apoptosis of tumor cells. The hepatopoietin PCn (HPPCn) and its homologous proteins are useful for the treatment of acute and chronic liver injury, or the treatment of liver fibrosis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully